CRON

3.16

0.16% 0.005

Dopo l'orario di chiusura: 3.16

Cronos Group Inc (CRON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$3.155

Aprire:

$3.12

Volume 24 ore:

584.12K

Relative Volume:

0.51

Capitalizzazione di mercato:

$1.16B

Reddito:

$159.54M

Utile/perdita netta:

$5.06M

Rapporto P/E:

-718.18

EPS:

-0.0044

Flusso di cassa netto:

$26.19M

1 W Prestazione:

-3.07%

1M Prestazione:

+5.33%

6M Prestazione:

+25.40%

1 anno Prestazione:

+24.90%

Intervallo 1D:

$3.12

$3.19

Intervallo di 1 settimana:

$3.12

$3.27

Portata 52W:

$2.28

$3.6077

Cronos Group Inc Stock (CRON) Company Profile

Nome

Cronos Group Inc

Settore

Healthcare (1069)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

(416) 504-0004

Indirizzo

4491 CONCESSION RD 12, STAYNER, ON

Dipendente

610

Cinguettio

@cronosgroup

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

CRON's Discussions on Twitter

Compare CRON vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRON Cronos Group Inc	3.16	1.16B	159.54M	5.06M	26.19M	-0.0044
TAK Takeda Pharmaceutical Co Adr	18.11	58.15B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.35	42.94B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.22	40.59B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.86	30.29B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	503.86	21.74B	3.17B	1.29B	1.01B	27.09

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-27	Iniziato	Canaccord Genuity	Buy
2022-11-02	Iniziato	Bernstein	Mkt Perform
2022-07-28	Aggiornamento	Canaccord Genuity	Hold → Buy
2022-05-11	Aggiornamento	CIBC	Neutral → Sector Outperform
2022-03-22	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-27	Aggiornamento	Jefferies	Underperform → Hold
2021-11-18	Ripresa	BofA Securities	Underperform
2021-04-28	Ripresa	BofA Securities	Underperform
2021-02-22	Downgrade	CIBC	Sector Outperform → Neutral
2020-06-24	Aggiornamento	Raymond James	Mkt Perform → Outperform
2020-04-27	Downgrade	Raymond James	Outperform → Mkt Perform
2020-04-14	Downgrade	Piper Sandler	Overweight → Neutral
2020-04-02	Downgrade	BofA/Merrill	Buy → Neutral
2020-03-31	Downgrade	Canaccord Genuity	Hold → Sell
2020-03-04	Aggiornamento	MKM Partners	Neutral → Buy
2020-03-03	Downgrade	Stifel	Buy → Hold
2019-10-18	Aggiornamento	Stifel	Hold → Buy
2019-09-20	Iniziato	MKM Partners	Neutral
2019-09-05	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Iniziato	Piper Jaffray	Overweight
2019-08-09	Aggiornamento	Canaccord Genuity	Sell → Hold
2019-06-28	Iniziato	Consumer Edge Research	Equal Weight
2019-06-06	Iniziato	Stifel	Hold
2019-06-05	Aggiornamento	BofA/Merrill	Underperform → Buy
2019-04-17	Iniziato	BofA/Merrill	Underperform
2019-03-27	Downgrade	Canaccord Genuity	Hold → Sell
2019-02-25	Iniziato	Jefferies	Underperform
2019-01-18	Iniziato	CIBC	Sector Outperform

Mostra tutto

Cronos Group Inc Borsa (CRON) Ultime notizie

02:56 AM

Cronos Group (NASDAQ:CRON): What's Moving During A Choppy Session? - Kalkine Media

02:56 AM

Sep 09, 2026

Cronos Group (TSX:CRON) Gains Attention Amid Cannabis Sector Shifts - Kalkine Media

Sep 09, 2026

Can Cronos Group (TSX:CRON) Sustain Its Growth Momentum? - Kalkine Media

Sep 09, 2026

Sep 08, 2026

Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch

Sep 08, 2026

Could Cronos Group Inc. (TSX:CRON) Drive Cannabis Stock Interest? - Kalkine Media

Sep 08, 2026

Cronos Group Inc (TSX:CRON): Why Cannabis Market Trends Matter? - Kalkine Media

Sep 08, 2026

Cronos Group (NASDAQ:CRON): Steady Growth Behind A Quiet Cannabis Name - Kalkine Media

Sep 08, 2026

Why Are These Canadian Penny Stocks Turning Heads? - Kalkine Media

Sep 08, 2026